Atenolol
Active pharmaceutical substance formulated in Jan Aushadhi generic products for Cardiac & Hypertension treatment.
🧴 Clinical Application
Take orally once daily with a glass of water, with or without meals, preferably at the same time each morning. Never discontinue abruptly; taper gradually over 1 to 2 weeks to prevent rebound angina or myocardial infarction.
⚠️ Side Effects
Common: Peripheral ankle edema, bradycardia, dizziness, headache, fatigue, cold extremities, flushing. Rare/Severe: Boxed warning: Abrupt cessation can precipitate severe angina/myocardial infarction; severe heart block, bronchospasm, and heart failure.
🛡️ Safety Warnings
Boxed warning for sudden beta-blocker withdrawal. Contraindicated in sinus bradycardia, second- or third-degree AV block, cardiogenic shock, and severe asthma. Monitor pulse and blood pressure regularly.
Jan Aushadhi Products containing Atenolol
Found 10 generic formulation(s) containing this active ingredient.
Amlodipine 5mg + Atenolol 50mg Tablets
Amlodipine and Atenolol is a classic dual-mechanism cardiovascular combination pairing a dihydropyridine calcium channel blocker with a cardioselective beta-1 blocker. Amlodipine lowers peripheral vascular resistance and dilates coronary arteries, while atenolol reduces resting and exercise heart rates, suppresses cardiac contractility, and eliminates the reflex tachycardia typically triggered by dihydropyridine vasodilation. Indicated for essential hypertension and stable chronic angina pectoris.
Atenolol Tablets 50 mg
Beta-adrenergic receptor antagonist (cardioselective beta-1 blocker, non-selective beta blocker, or third-generation vasodilating beta-blocker with alpha-blockade or nitric oxide release) on the WHO Model List of Essential Medicines. It competitively blocks adrenergic stimulation, reducing heart rate, myocardial contractility, cardiac output, and renin release. Indicated for hypertension, stable angina pectoris, heart failure, cardiac arrhythmias, and post-myocardial infarction secondary prevention.
Atenolol 25mg + Amlodipine 5mg Tablets
Amlodipine and Atenolol is a classic dual-mechanism cardiovascular combination pairing a dihydropyridine calcium channel blocker with a cardioselective beta-1 blocker. Amlodipine lowers peripheral vascular resistance and dilates coronary arteries, while atenolol reduces resting and exercise heart rates, suppresses cardiac contractility, and eliminates the reflex tachycardia typically triggered by dihydropyridine vasodilation. Indicated for essential hypertension and stable chronic angina pectoris.
Atenolol Tablets 25mg
Beta-adrenergic receptor antagonist (cardioselective beta-1 blocker, non-selective beta blocker, or third-generation vasodilating beta-blocker with alpha-blockade or nitric oxide release) on the WHO Model List of Essential Medicines. It competitively blocks adrenergic stimulation, reducing heart rate, myocardial contractility, cardiac output, and renin release. Indicated for hypertension, stable angina pectoris, heart failure, cardiac arrhythmias, and post-myocardial infarction secondary prevention.
S(-) Amlodipine 2.5mg + Atenolol 50mg Tablets
Amlodipine and Atenolol is a classic dual-mechanism cardiovascular combination pairing a dihydropyridine calcium channel blocker with a cardioselective beta-1 blocker. Amlodipine lowers peripheral vascular resistance and dilates coronary arteries, while atenolol reduces resting and exercise heart rates, suppresses cardiac contractility, and eliminates the reflex tachycardia typically triggered by dihydropyridine vasodilation. Indicated for essential hypertension and stable chronic angina pectoris.
Atenolol + Chlorthalidone Tablet (25/12.5 Mg)
Beta-adrenergic receptor antagonist (cardioselective beta-1 blocker, non-selective beta blocker, or third-generation vasodilating beta-blocker with alpha-blockade or nitric oxide release) on the WHO Model List of Essential Medicines. It competitively blocks adrenergic stimulation, reducing heart rate, myocardial contractility, cardiac output, and renin release. Indicated for hypertension, stable angina pectoris, heart failure, cardiac arrhythmias, and post-myocardial infarction secondary prevention.
Atenolol + Chlorthalidone Tablet (50/12.5 Mg)
Beta-adrenergic receptor antagonist (cardioselective beta-1 blocker, non-selective beta blocker, or third-generation vasodilating beta-blocker with alpha-blockade or nitric oxide release) on the WHO Model List of Essential Medicines. It competitively blocks adrenergic stimulation, reducing heart rate, myocardial contractility, cardiac output, and renin release. Indicated for hypertension, stable angina pectoris, heart failure, cardiac arrhythmias, and post-myocardial infarction secondary prevention.
Atenolol + Indapamide Tablet (50/2.5 Mg)
Beta-adrenergic receptor antagonist (cardioselective beta-1 blocker, non-selective beta blocker, or third-generation vasodilating beta-blocker with alpha-blockade or nitric oxide release) on the WHO Model List of Essential Medicines. It competitively blocks adrenergic stimulation, reducing heart rate, myocardial contractility, cardiac output, and renin release. Indicated for hypertension, stable angina pectoris, heart failure, cardiac arrhythmias, and post-myocardial infarction secondary prevention.
Atenolol + Losartan Tablet (50/50 Mg)
Losartan Potassium is the prototype selective competitive angiotensin II receptor type 1 (AT1) antagonist on the WHO Model List of Essential Medicines. It blocks the physiological actions of angiotensin II, lowering systemic vascular resistance and aldosterone secretion, while its active metabolite EXP3174 provides long-acting non-competitive blockade. Possesses unique uricosuric activity, lowering serum uric acid levels. Indicated for essential hypertension, diabetic nephropathy in type 2 diabetes with elevated creatinine and proteinuria, and stroke reduction in hypertensive patients with left ventricular hypertrophy.
Atenolol + Nifedipine Tablet (50/20 Mg)
Beta-adrenergic receptor antagonist (cardioselective beta-1 blocker, non-selective beta blocker, or third-generation vasodilating beta-blocker with alpha-blockade or nitric oxide release) on the WHO Model List of Essential Medicines. It competitively blocks adrenergic stimulation, reducing heart rate, myocardial contractility, cardiac output, and renin release. Indicated for hypertension, stable angina pectoris, heart failure, cardiac arrhythmias, and post-myocardial infarction secondary prevention.
Brand Equivalents & Price Comparison
Compare Jan Aushadhi generic prices against popular commercial brands for Atenolol.
| Generic Formulation | Pack Size | Jan Aushadhi Price | Commercial Brand Equivalents | Avg. Commercial Price | Savings |
|---|---|---|---|---|---|
| Amlodipine 5mg + Atenolol 50mg Tablets | 10's | ₹7.22 | AMLOKIND, AMLOPIN, AMLIP, AMLOPRES, AMODEP | ₹88.12 | 92% Save |
| Atenolol Tablets 50 mg | 14's | ₹6.81 | ATEN, HIPRES, TENOLOL, ZIBLOK | ₹27.56 | 75% Save |
| Atenolol 25mg + Amlodipine 5mg Tablets | 14's | ₹16.50 | AMLOPRES | ₹114.54 | 86% Save |
| Atenolol Tablets 25mg | 14's | ₹6.19 | ATEN, TENOLOL, TENORMIN, ZIBLOK, HIPRES | ₹39.78 | 84% Save |
| S(-) Amlodipine 2.5mg + Atenolol 50mg Tablets | 10's | ₹14.06 | N/A | N/A | N/A |
| Atenolol + Chlorthalidone Tablet (25/12.5 Mg) | 10's | Under Process | N/A | N/A | N/A |
| Atenolol + Chlorthalidone Tablet (50/12.5 Mg) | 10's | Under Process | N/A | N/A | N/A |
| Atenolol + Indapamide Tablet (50/2.5 Mg) | 10's | Under Process | N/A | N/A | N/A |
| Atenolol + Losartan Tablet (50/50 Mg) | 10's | Under Process | N/A | N/A | N/A |
| Atenolol + Nifedipine Tablet (50/20 Mg) | 10's | Under Process | N/A | N/A | N/A |
Frequently Asked Questions (FAQ)
Get answers to common queries about Atenolol generics.